Neuroprotective potential of Glibenclamide (cas 10238-21-8) is mediated by antioxidant and anti-apoptotic pathways in intracerebral hemorrhage
-
Add time:07/26/2019 Source:sciencedirect.com
The sulfonylurea receptor 1 (SUR1)-regulated NCca-ATP channels were progressively upregulated and demonstrated unchecked opening in central nervous system (CNS) injury, which induced cerebral damage. Glibenclamide (cas 10238-21-8) (GLI) can block NCca-ATP channels and consequently exert protective effects. Recent studies have found that GLI has antioxidative effects. In this study, we primarily explored the antioxidative effects of GLI in a rat model of intracerebral hemorrhage (ICH). We found that GLI could scavenge free radicals, reduce activated-caspase-3 expression, increase the Bcl-2/Bax ratio, inhibit apoptosis, and improve functional neurological outcomes in a rat model of ICH.
We also recommend Trading Suppliers and Manufacturers of Glibenclamide (cas 10238-21-8). Pls Click Website Link as below: cas 10238-21-8 suppliers
Prev:Role of AKR1C3 in renal injury and Glibenclamide (cas 10238-21-8) is anti-inflammatory in preeclamptic rats
Next:Low-voltage online stimulated microextraction of Glibenclamide (cas 10238-21-8) from whole blood) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Characterization and evaluation of different mesoporous silica kinds as carriers for the development of effective oral dosage forms of Glibenclamide (cas 10238-21-8)07/31/2019
- Controlled release of Glibenclamide (cas 10238-21-8) from monolithic silica subdermal implants produced by the sol-gel process and its use for hyperglycaemia treatment in a murine model07/30/2019
- Effects of dexmedetomidine and MK-467 on plasma glucose, insulin and glucagon in a Glibenclamide (cas 10238-21-8)-induced canine hypoglycaemia model07/29/2019
- Peceosomes for oral delivery of Glibenclamide (cas 10238-21-8): In vitro in situ correlation07/28/2019
- Low-voltage online stimulated microextraction of Glibenclamide (cas 10238-21-8) from whole blood07/27/2019
- Role of AKR1C3 in renal injury and Glibenclamide (cas 10238-21-8) is anti-inflammatory in preeclamptic rats07/25/2019
- Electrochemical detection of gliclazide and Glibenclamide (cas 10238-21-8) on ZnIn2S4 nanoparticles-modified carbon ionic liquid electrode07/24/2019
- Studying tautomerism in an important pharmaceutical Glibenclamide (cas 10238-21-8) confined in the thin nanometric layers07/23/2019